Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

As the effect of statin use before the angiography to prevent contrast induced nephropathy (CIN) is not well-known, the aim of the current study is to assess the effect of atorvastatin on prevention of CIN in patients undergoing coronary angiography.

• Phase: Phase 3

Details

• Lead Sponsor: Isfahan University of Medical Sciences
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• having chronic stable angina who were referred for coronary angiography

• non-pregnant female subjects

• no history of diabetes mellitus

• no history of renal failure

• no history of single kidney

• no history of cardiogenic shock

• no history of unstable angina

• no history of myocardial infarction

• no history of hypersensitivity to statins

• no history of previous intravascular contrast injection during one month before admission

Exclusion Criteria:

• glomerular filtration rate (GFR) <60

• cardiogenic shock